In vitro fertilization (IVF) offers hope to many couples struggling with infertility. However, a recent lawsuit has raised serious concerns about the practices of Aspire Houston Fertility Institute (Aspire HFI), a Houston fertility clinic, and CooperSurgical, a fertility technology company. Five couples seeking IVF at Aspire HFI have initiated legal action alleging that the fertility clinic used faulty technology from CooperSurgical to freeze their embryos, eggs, and sperm for IVF, leading to the “massive loss of viable embryos.”
The Alarcons’ Embryo Loss Claims
Nicole and Agustin Alarcon, one of the couples named in the IVF embryo loss lawsuit against Aspire HFI and CooperSurgical, sought IVF treatment at the Houston fertility clinic after years of unsuccessful attempts to conceive. Initially encouraged by the production of 14 viable embryos, the couple faced disappointment with three failed transfers, including one miscarriage.
The Alarcons’ investigation into their unsuccessful attempts led to a concerning discovery. They were informed by their doctor about a “lab issue” affecting embryos stored at Aspire HFI’s Piney Point facility in Houston, Texas.
The lawsuit alleges that this issue stemmed from a defective freezing medium supplied by CooperSurgical, a California-based company specializing in fertility and women’s health products. According to court documents, this faulty solution resulted in a “catastrophic failure,” leading to a substantial loss of viable embryos.
Allegations Raised Against Aspire HFI
The lawsuit, brought by five Houston couples, alleges that Aspired HFI continued to implant potentially damaged or non-viable embryos into patients without disclosing the known issue. It asserts that the fertility clinic’s alleged actions constituted a breach of trust, potentially exposing patients to unnecessary medical risks and emotional distress.
Fertility Clinic Denies Claims
Aspire HFI has denied the allegations in the lawsuit, asserting that they “never knowingly transferred non-viable tissue.” The fertility clinic acknowledged a “minor decrease in thawing survival rates for embryos frozen in our Houston Piney Point laboratory” during the period specified in the lawsuit. They stated that the issue was promptly addressed by discontinuing the use of the problematic freezing medium.
Aspire HFI further claimed that their “survival rates returned to our industry-leading standards” after reverting to their previously used freezing medium. However, the lawsuit alleges that the couples were not informed of the issue promptly, and that Aspire HFI continued to implant potentially compromised embryos. CooperSurgical has not commented on the allegations.
Additional IVF Embryo Loss Claims Against CooperSurgical
This is not the first time CooperSurgical has faced such allegations. The fertility technology company faces multiple lawsuits over claims of embryo loss related to its recalled embryo culture media. The complaints have been brought by families across the United States, collectively claiming the loss of over 100 embryos.
These lawsuits against CooperSurgical allege that batches of the company’s culture media were missing a key nutrient, magnesium, which stopped embryos from developing and rendered them unusable. The FDA posted a recall notice for nearly 1,000 bottles of the affected culture media, with about half purchased by U.S. clinics. Experts estimate that thousands of patients could have been affected if even half of the recalled bottles were used before the December 2023 recall notice.
CooperSurgical IVF Solution Lawsuit Information
Coopersurgical IVF Solution Recall, Leading Justice
Class 2 Device Recall global Medium, FDA
